TY - JOUR
T1 - TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors
T2 - Evaluation of different classification model combinations using bond-based linear indices
AU - Casañola-Martín, Gerardo M.
AU - Marrero-Ponce, Yovani
AU - Khan, Mahmud Tareq Hassan
AU - Ather, Arjumand
AU - Sultan, Sadia
AU - Torrens, Francisco
AU - Rotondo, Richard
N1 - Funding Information:
One of the authors (M.-P. Y) thanks Prof. Dr. Ramón García Domenech for the revision of manuscript. Their numerous comments and suggestions on the manuscript which resulted in a significant improvement of the material. The same author acknowledges the Valencia University for kind hospitality during the second semester of 2006. M.-P. Y thanks are also given to the Generalitat Valenciana, (Spain) for partial financial support as well as the program ‘Estades Temporals per an Investigadors Convidats’ for a fellowship to work at Valencia University (2006–2007). Some authors’ thanks support from Spanish MEC (Project Reference: SAF2006-04698). M.T.H.K is the recipient of a grant from MCBN-UNESCO (grant no. 1056), and fellowships from CIB (Italy) and Associasione Veneta per la Lotta alla Talassemia (AVTL, Italy). F.T. acknowledges financial support from the Spanish MEC DGI (Project No.CTQ2004-07768-C02-01/BQU) and Generalitat Valenciana (DGEUI INF01-051 and INFRA03-047, and OCYT GRUPOS03-173.
PY - 2007/2/1
Y1 - 2007/2/1
N2 - A new set of bond-level molecular descriptors (bond-based linear indices) are used here in QSAR (quantitative structure-activity relationship) studies of tyrosinase inhibitors, for finding functions that discriminate between the tyrosinase inhibitor compounds and inactive ones. A database of 246 compounds was collected for this study; all organic chemicals were reported as tyrosinase inhibitors; they had great structural diversity. This dataset can be considered as a helpful tool, not only for theoretical chemists but also for other researchers in this area. The set used as inactive has 412 drugs with other clinical uses. Twelve LDA-based QSAR models were obtained, the first six using the non-stochastic total and local bond-based linear indices as well as the last six ones, the stochastic molecular descriptors. The best two discriminant models computed using the non-stochastic and stochastic molecular descriptors (Eqs. 7 and 13, respectively) had globally good classifications of 98.95% and 89.75% in the training set, with high Matthews correlation coefficients (C) of 0.98 and 0.78. The external prediction sets had accuracies of 98.89% and 89.44%, and (C) values of 0.98 and 0.78, for models 7 and 13, respectively. A virtual screening of compounds reported in the literature with such activity was carried out, to prove the ability of present models to search for tyrosinase inhibitors, not included in the training or test set. At the end, the fitted discriminant functions were used in the selection/identification of new ethylsteroids isolated from herbal plants, looking for tyrosinase inhibitory activity. A good behavior is shown between the theoretical and experimental results on mushroom tyrosinase enzyme. It might be highlighted that all the compounds showed values under 10 μM and that ES2 (IC50 = 1.25 μM) showed higher activity in the inhibition against the enzyme than reference compounds kojic acid (IC50 = 16.67 μM) and l-mimosine (IC50 = 3.68 μM). In addition, a comparison with other established methods was carried to prove the adequate discriminatory performance of the molecular descriptors used here. The present algorithm provided useful clues that can be used to speed up in the identification of new tyrosinase inhibitor compounds.
AB - A new set of bond-level molecular descriptors (bond-based linear indices) are used here in QSAR (quantitative structure-activity relationship) studies of tyrosinase inhibitors, for finding functions that discriminate between the tyrosinase inhibitor compounds and inactive ones. A database of 246 compounds was collected for this study; all organic chemicals were reported as tyrosinase inhibitors; they had great structural diversity. This dataset can be considered as a helpful tool, not only for theoretical chemists but also for other researchers in this area. The set used as inactive has 412 drugs with other clinical uses. Twelve LDA-based QSAR models were obtained, the first six using the non-stochastic total and local bond-based linear indices as well as the last six ones, the stochastic molecular descriptors. The best two discriminant models computed using the non-stochastic and stochastic molecular descriptors (Eqs. 7 and 13, respectively) had globally good classifications of 98.95% and 89.75% in the training set, with high Matthews correlation coefficients (C) of 0.98 and 0.78. The external prediction sets had accuracies of 98.89% and 89.44%, and (C) values of 0.98 and 0.78, for models 7 and 13, respectively. A virtual screening of compounds reported in the literature with such activity was carried out, to prove the ability of present models to search for tyrosinase inhibitors, not included in the training or test set. At the end, the fitted discriminant functions were used in the selection/identification of new ethylsteroids isolated from herbal plants, looking for tyrosinase inhibitory activity. A good behavior is shown between the theoretical and experimental results on mushroom tyrosinase enzyme. It might be highlighted that all the compounds showed values under 10 μM and that ES2 (IC50 = 1.25 μM) showed higher activity in the inhibition against the enzyme than reference compounds kojic acid (IC50 = 16.67 μM) and l-mimosine (IC50 = 3.68 μM). In addition, a comparison with other established methods was carried to prove the adequate discriminatory performance of the molecular descriptors used here. The present algorithm provided useful clues that can be used to speed up in the identification of new tyrosinase inhibitor compounds.
KW - Ethylsteroid compounds
KW - LDA-based QSAR model
KW - Ligand-based virtual screening
KW - Non-stochastic and stochastic bond-based linear indices
KW - TOMOCOMD-CARDD software
KW - Tyrosinase inhibitor
UR - http://www.scopus.com/inward/record.url?scp=33845972688&partnerID=8YFLogxK
U2 - 10.1016/j.bmc.2006.10.067
DO - 10.1016/j.bmc.2006.10.067
M3 - Artículo
C2 - 17110117
AN - SCOPUS:33845972688
SN - 0968-0896
VL - 15
SP - 1483
EP - 1503
JO - Bioorganic and Medicinal Chemistry
JF - Bioorganic and Medicinal Chemistry
IS - 3
ER -